1. Fake DYSPORT batches identified in five countries

   News item 27 August 2022 Pages: 1 - 1

2. ISMP perioperative medication safety guidelines

   News item 27 August 2022 Pages: 2 - 2

3. Nitrosamine detected in quinapril products in Australia

   News item 27 August 2022 Pages: 3 - 3

4. Novavax COVID-19 vaccine-related myocarditis, pericarditis

   News item 27 August 2022 Pages: 4 - 4

5. pms-Hydromorphone lot recalled due to packaging error, risk of overdose

   News item 27 August 2022 Pages: 5 - 5

6. Pregabalin drug dependence and withdrawal symptoms

   News item 27 August 2022 Pages: 6 - 6

7. Warning against live vaccines after in utero exposure to infliximab

   News item 27 August 2022 Pages: 7 - 7

8. COVID-19 mRNA vaccines safe in pregnancy

   Clinical study 27 August 2022 Pages: 8 - 8

9. COVID-19 vaccination hesitancy may drive AE reporting

   Clinical study 27 August 2022 Pages: 9 - 9

10. Prescribed drugs associated with QT prolongation and TdP

    Clinical study 27 August 2022 Pages: 10 - 10

11. Risk of PI3K inhibitor-related cutaneous AEs

    Clinical study 27 August 2022 Pages: 11 - 11

12. Trastuzumab deruxtecan-related interstitial lung disease, pneumonitis

    Clinical study 27 August 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 27 August 2022 Pages: 13 - 13

14. Abacavir/stavudine/tenofovir-disoproxil-fumarate

    Case report 27 August 2022 Pages: 14 - 14

15. Aciclovir/betamethasone-butyrate-propionate/prednisolone

    Case report 27 August 2022 Pages: 15 - 15

16. Adenosine/amiodarone/sirolimus

    Case report 27 August 2022 Pages: 16 - 16

17. Afatinib/osimertinib

    Case report 27 August 2022 Pages: 17 - 17

18. Albumin-human/recombinant-erythropoietin/sunitinib

    Case report 27 August 2022 Pages: 18 - 18

19. Allopurinol/azathioprine

    Case report 27 August 2022 Pages: 19 - 19

20. Alteplase

    Case report 27 August 2022 Pages: 20 - 20

21. Amiodarone

    Case report 27 August 2022 Pages: 21 - 21

22. Amiodarone/atenolol

    Case report 27 August 2022 Pages: 22 - 22

23. Amiodarone/metoprolol

    Case report 27 August 2022 Pages: 23 - 23

24. Amoxicillin/clavulanic-acid/doxycycline

    Case report 27 August 2022 Pages: 24 - 24

25. Amphotericin-B/amphotericin-B-liposomal/flucytosine

    Case report 27 August 2022 Pages: 25 - 25

26. Anabolic-steroids

    Case report 27 August 2022 Pages: 26 - 26

27. Antibacterials/bezlotoxumab/zonisamide

    Case report 27 August 2022 Pages: 27 - 27

28. Antibacterials/glucocorticoids

    Case report 27 August 2022 Pages: 28 - 28

29. Antiepileptic drugs

    Case report 27 August 2022 Pages: 29 - 29

30. Antiepileptics

    Case report 27 August 2022 Pages: 30 - 30

31. Antifungals/prednisolone/tofacitinib

    Case report 27 August 2022 Pages: 31 - 31

32. Antihyperglycaemics

    Case report 27 August 2022 Pages: 32 - 32

33. Antineoplastics

    Case report 27 August 2022 Pages: 33 - 33

34. Antineoplastics

    Case report 27 August 2022 Pages: 34 - 34

35. Antineoplastics

    Case report 27 August 2022 Pages: 35 - 35

36. Antineoplastics

    Case report 27 August 2022 Pages: 36 - 36

37. Antineoplastics

    Case report 27 August 2022 Pages: 37 - 37

38. Antineoplastics

    Case report 27 August 2022 Pages: 38 - 38

39. Antineoplastics

    Case report 27 August 2022 Pages: 39 - 39

40. Antineoplastics

    Case report 27 August 2022 Pages: 40 - 40

41. Antineoplastics

    Case report 27 August 2022 Pages: 41 - 41

42. Antineoplastics

    Case report 27 August 2022 Pages: 42 - 42

43. Antineoplastics

    Case report 27 August 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 27 August 2022 Pages: 44 - 44

45. Antineoplastics/Glucocorticoids/Proton pump inhibitors

    Case report 27 August 2022 Pages: 45 - 45

46. Antineoplastics/pirarubicin

    Case report 27 August 2022 Pages: 46 - 46

47. Apixaban/aspirin/enoxaparin sodium

    Case report 27 August 2022 Pages: 47 - 47

48. Apixaban/warfarin

    Case report 27 August 2022 Pages: 48 - 48

49. Aripiprazole/fluoxetine/olanzapine

    Case report 27 August 2022 Pages: 49 - 49

50. Atezolizumab

    Case report 27 August 2022 Pages: 50 - 50